Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
Soleus Capital Management, L.P. Buys DICE Therapeutics Inc, United Therapeutics Corp, Flexion ...
11:38pm, Monday, 15'th Nov 2021 GuruFocus
Related Stocks: LNTH , CDNA , SRDX , SIEN , EPIX , NPCE , DICE , UTHR , FLXN , ENTA , ORGO , NRIX , MDXG , RVMD , TKNO , GLTO , PODD , DXCM ,
United Therapeutics Corp (UTHR) Chairman & CEO Martine A Rothblatt Sold $627,236 of Shares
11:15pm, Monday, 15'th Nov 2021 GuruFocus
Related Stocks: UTHR ,
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Invesco Ltd.
01:20pm, Sunday, 14'th Nov 2021 Transcript Daily
Invesco Ltd. reduced its holdings in United Therapeutics Co. (NASDAQ:UTHR) by 10.2% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 568,135 shares of the biotechnology companys stock after selling 64,621 shares during the quarter. Invesco Ltd.s holdings in United Therapeutics were worth $101,929,000 at the end of the most recent reporting period. []
United Therapeutics (UTHR) Q3 Earnings & Sales Beat, Stock Up
10:42am, Thursday, 04'th Nov 2021
United Therapeutics (UTHR) third-quarter earnings and sales beat estimates. Higher sales of Orenitram and Tyvaso mainly drive the top line in the quarter.
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q3 2021 Results - Earnings Call Transcript
02:49pm, Wednesday, 03'rd Nov 2021
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q3 2021 Results - Earnings Call Transcript
United Therapeutics (UTHR) Q3 Earnings and Revenues Surpass Estimates
08:26am, Wednesday, 03'rd Nov 2021
United Therapeutics (UTHR) delivered earnings and revenue surprises of 1.48% and 6.93%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference
06:00am, Monday, 01'st Nov 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021
06:00am, Wednesday, 27'th Oct 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
Is This Beaten Down Biotech a Bad News Buy?
07:00am, Wednesday, 20'th Oct 2021
It has lagged the market over the last five years but with a promising gene therapy, is Sarepta worth another look?
United Therapeutics' (UTHR) Tyvaso DPI NDA Gets CRL From FDA (Revised)
03:06am, Wednesday, 20'th Oct 2021
United Therapeutics' (UTHR) new drug application for Tyvaso DPI to treat PAH & PH-ILD fails to secure approval from the FDA. The stock declines resultantly.
UTHR Stock: Why The Price Fell Today
08:48am, Monday, 18'th Oct 2021
The stock price of United Therapeutics Corporation (NASDAQ: UTHR) fell by over 1% today. This is why it happened.
FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease
08:45am, Monday, 18'th Oct 2021
The FDA has issued a complete response to United Therapeutics Corporation (NASDAQ: UTHR) regarding the marketing application for Tyvaso DPI for pulmonary arterial hypertension (PAH) and pulmonary
United Therapeutics to Present New Data at CHEST Annual Meeting 2021
06:00am, Monday, 11'th Oct 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
7 Top-Rated Pharmaceutical Stocks To Invest in for October
10:01am, Monday, 04'th Oct 2021
It's a great time to look beyond the big name pharmaceutical stocks and look for great niche players with big futures. The post 7 Top-Rated Pharmaceutical Stocks To Invest in for October appeared firs
United Therapeutics Converts to a Public Benefit Corporation Following Shareholder Approval
04:30pm, Thursday, 30'th Sep 2021
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C.
